ConsultantUC San Diego Moores Cancer CenterLa Jolla, California, United States
Disclosure information not submitted.
Paper 83 - AN OPEN-LABEL, PHASE II EFFICACY STUDY OF TEMOZOLOMIDE IN ADVANCED SUCCINATE DEHYDROGENASE-MUTANT/DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Saturday, November 4, 20233:00 PM – 4:00 PM